|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2010-8-10
|
|
pubmed:abstractText |
Low-grade inflammation is thought to contribute to the development of cardiovascular disease (CVD), type-2 diabetes mellitus (T2D), cancer and mortality. Biomarkers of inflammation may aid in risk prediction and enable early intervention and prevention of disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1365-2796
|
|
pubmed:author |
pubmed-author:AndersenOO,
pubmed-author:Borch-JohnsenKK,
pubmed-author:Eugen-OlsenJJ,
pubmed-author:FengerMM,
pubmed-author:HansenT WTW,
pubmed-author:HaugaardS BSB,
pubmed-author:HildebrandtP RPR,
pubmed-author:JørgensenTT,
pubmed-author:JeppesenJJ,
pubmed-author:LadelundSS,
pubmed-author:LangkildeAA,
pubmed-author:LinnebergAA,
pubmed-author:LyngbaekSS,
pubmed-author:MøllerL NLN,
pubmed-author:OlsenM HMH,
pubmed-author:PetersenJJ,
pubmed-author:PielakTT
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
268
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
296-308
|
|
pubmed:meshHeading |
pubmed-meshheading:20561148-Adult,
pubmed-meshheading:20561148-Age Distribution,
pubmed-meshheading:20561148-Aged,
pubmed-meshheading:20561148-Biological Markers,
pubmed-meshheading:20561148-C-Reactive Protein,
pubmed-meshheading:20561148-Cardiovascular Diseases,
pubmed-meshheading:20561148-Denmark,
pubmed-meshheading:20561148-Diabetes Mellitus, Type 2,
pubmed-meshheading:20561148-Epidemiologic Methods,
pubmed-meshheading:20561148-Female,
pubmed-meshheading:20561148-Humans,
pubmed-meshheading:20561148-Male,
pubmed-meshheading:20561148-Middle Aged,
pubmed-meshheading:20561148-Neoplasms,
pubmed-meshheading:20561148-Prognosis,
pubmed-meshheading:20561148-Receptors, Urokinase Plasminogen Activator,
pubmed-meshheading:20561148-Sex Distribution,
pubmed-meshheading:20561148-Tumor Markers, Biological
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population.
|
|
pubmed:affiliation |
Clinical Research Centre, Copenhagen University, Hvidovre Hospital, Hvidovre, Denmark. jeo@biobase.dk
|
|
pubmed:publicationType |
Journal Article
|
